OsteoBites S2 Ep2: Alejandro Sweet Cordero, MD "Genome-Informed Targeted Therapies for Osteosarcoma"

MIB Agents OsteoBites S2 Ep2: Alejandro Sweet Cordero, MD on Genome-Informed Targeted Therapies for Osteosarcoma. Guest Information: Alejandro Sweet-Cordero, MD is a physician-scientist focused on basic and translational sarcoma biology. His interest is in mechanisms driving osteosarcoma and Ewing sarcoma progression, metastasis and therapy resistance.  They use patient-derived xenografts and direct analysis of patient tumors as tools for gene discovery. The Sweet-Cordero Lab has expertise in integrative genomic analysis and extensive experience in generating next-generation sequencing datasets for gene and network discovery using both primary tumors and human and mouse model systems. ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org … What We Do PROGRAMS: ✨ End-of-Life MISSIONS ✨ Gamer Agents ✨ Agent Writers ✨ Prayer Agents ✨ Healing Hearts Bereaved Parent Support ✨ Ambassador Agents - Peer Support EDUCATION for physicians, researchers and families: ✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma ✨ MIB Book: Osteosarcoma: From our Families to Yours RESEARCH: ✨ Annual MIB FACTOR Research Conference ✨ Funding $100,000 annually for OS research ✨ MIB Testing & Research Directory ✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard .... Kids are still dying with 40+ year old treatments. Help us MakeItBetter. 🔗 https://www.mibagents.org